Feng Liu

Feng Liu is an experienced professional in the field of biometrics, currently serving as the Head of Biometrics at Immunocore since April 2024. Prior to this role, Feng Liu held a similar position at Marengo Therapeutics, overseeing the biometrics function to support a growing clinical portfolio. As a Senior Director at Fate Therapeutics Inc, Feng Liu led statistical activities for the development of cell therapies targeting lymphoma and solid tumors. Previous roles include Senior Director of Biostatistics at Intercept Pharmaceuticals, where Feng Liu managed teams in phase 3 clinical studies, and Statistical Science Director at AstraZeneca, providing expertise in late oncology clinical development. Early career experiences include leading statistics at GSK and working as a biostatistician at Quintiles. Feng Liu holds a PhD in Statistics from The University of Sheffield, along with two master's degrees in Statistics and Biochemistry and Molecular Biology from Iowa State University, and a bachelor's degree in Chemistry from Peking University.